This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Ebola: Managing to Save Lives
IESE InsightArticle ART-2676-EService and Operations ManagementA year after the outbreak of Ebola in West Africa in March 2014, health-care experts are cautiously optimistic that the epidemic appears to be slowing. Although the outlook is brighter than a year ago when the first case was detected in Guinea, there is still a long way to go and many lessons to be learned in managing a crisis of this scale, related to institutional shortfalls, international coordination, engagement with local stakeholders and, m...Starting at €8.20
-
Untapping Innovation
IESE InsightArticle ART-2795-EBusiness Ethics and Corporate Social Responsibility, Innovation and ChangeWhy do some innovations take off, while others languish? "Things cannot happen before their time," cautions Igal Aisenberg, a dairy farmer turned agricultural businessman who worked for Netafim, maker of drip irrigation systems. In this article he discusses the conflux of conditions that leads to the adoption of disruptive technology, and he underscores the importance of a business having social ends.Starting at €8.20
-
Myer and Flanagan (A): High-Stake Recruitment at the Top
Reiche, Sebastian; Akkan, ErenCase DPO-352-EBusiness Ethics and Corporate Social Responsibility, Leadership and People ManagementThis 2-case series focuses on the challenges of senior executive replacements at Australian department store Myer. In late spring of 2014, Myer was going through a major reshuffle of its senior management team. More than 20 senior managers had left the company over the past 2 years, and the exodus of some key members of the executive team was continuing. The turnover had accelerated after CEO Bernie Brookes decided in February 2014 to remain in h...Starting at €8.20
-
Nacre (A): la transformación de una idea de laboratorio a una empresa de alto crecimiento: Los retos de comercializar un dispositivo tecnológico innovador
Prats, Mª Julia; Sosna, Marc; Darsch, DaveFocused Case EFC-2Entrepreneurship, Innovation and ChangeEste caso habla sobre un director general que se puso al frente de una spin-off creada a partir de un instituto de investigación, se convirtió en el primer empleado de la nueva empresa y trató de convertir esa idea de laboratorio en un prototipo con el objetivo de producirlo industrialmente y venderlo finalmente a un cliente muy exigente, afrontando entre tanto varias crisis notables. Además de las dificultades para conseguir que el producto (un...Starting at €8.20
-
Nacre (B): una cuesta empinada y arriesgada hacia el éxito: Decisiones y consecuencias
Prats, Mª Julia; Sosna, Marc; Darsch, DaveFocused Case EFC-7Entrepreneurship, Innovation and ChangeEste caso B no puede impartirse de manera aislada, pues es una continuación directa del caso "Nacre: cómo convertir una idea de laboratorio en una empresa de alto crecimiento" (A) [EFC-2-E]. En el caso B se describen las decisiones y medidas estratégicas del director general y cómo esta empresa (que tan sólo tenía entre 12 y 15 empleados en aquel momento y subcontrataba los servicios de un gran fabricante) consiguió finalmente cerrar un contrato...Starting at €8.20
-
Nacre (A): Turning a Lab Idea into a High-Growth Firm: The challenges of bringing an innovative device technology to market
Prats, Mª Julia; Sosna, Marc; Darsch, DaveFocused Case EFC-2-EEntrepreneurship, Innovation and ChangeThis FocusCase is about a CEO who took over a spin-off from a research institute, became the new firm's employee #1 and tried to turn this lab idea into a prototype, then get it ready for industrialization, and finally sell it to a very demanding client, while facing some significant crises on this way. Beside the challenge of getting the product (an integrated hearing protection and communication device) working and a painful failure with a cont...Starting at €8.20
-
Ashby Pharmaceuticals
Muñoz-Cobo, Diego; Villanueva, JulianCase M-1208-EMarketingJames Conica had just been appointed new sales director of the company Ashby Pharmaceuticals, which sold pharmaceutical products. His task was to substantially improve the performance of the sales force, which according to company director Ian Thompson, had ample scope for improvement.Starting at €8.20
-
APY Art Centre Collective: Taking Indigenous Art to the City
Theodore L. Hill; Sheri Lambert; Kathryn ReadyCase IVEY-9B21M019-EStrategyIn early 2019, just a year after opening a gallery in Sydney, Australia, the elders of the APY Art Centre Collective proposed opening a second gallery in Adelaide, a much smaller city. The first year in Sydney had been profitable, in part due to an aggressive digital presence. The Collective had some seed money, an offer of a small gallery space, and the draw of serving a large number of the APY community who were residents in Adelaide. But the A...Starting at €8.20
-
Zip: In Need of Growth-Oriented Competitive Strategies
Arpita Agnihotri; Saurabh BhattacharyaCase IVEY-9B21M025-EStrategyZip Co Limited (Zip) was a market follower in the Australian buy now, pay later (BNPL) sector. In September 2020, PayPal Holdings Inc. entered the growing sector, which was expected to disrupt the credit card industry, with better incentives for retailers and consumers. Although investors were concerned, Zip’s chief executive officer remained confident about the company’s future growth. How could he combat competition against large players like P...Starting at €8.20
-
Domino’s Pizza Enterprises (Australia): Weighted Average Cost of Capital
Colette Southam; Paul W. Beamish; Matthew WinklerCase IVEY-W25568-EFinanceOn November 4, 2020, the group chief financial officer of Domino’s Pizza Enterprises Limited was tasked with determining the cost of capital in preparation for the corporate response to the COVID-19 pandemic. In planning for 2021, the company would need to make considerable investments throughout its franchises in Australia, New Zealand, Japan, and Europe. The cost of capital would be integral to these investment decisions. In the previous year, ...Starting at €8.20